China Resources Boya Bio-pharmaceutical Group (300294.SZ) has been approved to establish a single blood plasma collection station in Dalad Banner, Ordos City, Inner Mongolia.

China Resources Boya Bio-pharmaceutical Group (300294.SZ) announced that on January 5, 2025, the company received approval from the Inner Mongolia Autonomous Region Health Commission to establish a single plasma collection station in Dalat Qi, Inner Mongolia ERDOS Resources City. The company will accelerate the construction of the plasma collection station and handle the related practice registration procedures in accordance with the regulations such as the "Regulations on Blood Products Management" and the "Management Measures for Single Plasma Collection Stations". Once the plasma collection station is completed and passes inspection, it will help to further enhance the company's supply capacity of raw plasma, and increase the company's profitability.